Skip to content
DataLookout
Menu

NCT07645352

Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS7 Zimbabwe

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 7 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Study completion pushed from Dec 31, 2027 to May 31, 2028
  2. Notable Recruitment opened
    • Site details revised
  3. Notable Primary and study completion pushed from May 31, 2027 to Dec 31, 2027
  4. Notable Eligibility criteria expanded, about 16 words
    • Start date: Oct 2026 to Oct 15, 2026
    • Collaborators: details revised at 1 of 6 entries
  5. Notable Start date: Jun 2026 to Oct 2026v2
  6. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Proportion of participants with persistent HPV at 6 months
Timeframe: From enrollment to follow up at 6 months

Arms and interventions

Group 1 (TA with 1 probe)Experimental

Participants undergo a clinical exam, soft-brush endocervical and ectocervical biopsies, digital imaging, and visual assessment for TA, and if eligible undergo TA with 1 probe at month 0.

Group 2 (TA with 2 probes)Experimental

Participants undergo a clinical exam, soft-brush endocervical and ectocervical biopsies, digital imaging, and visual assessment for TA, and if eligible undergo TA with 2 probes at month 0.

Procedures: Thermal ablation (TA) with 1 probe, Thermal ablation (TA) with 2 probes

Sites

1 site in 1 country

  • University of Zimbabwe, Centre for ResearchHarare, Zimbabwe